HIF1A and neoplasm: HIF-1α promotes EMT in cancer cells by activating the transcription of genes in the LOX family [27,28,29], and induces angiopoietin-like-4 (ANGPTL4), resulting in tumor growth and resistance to anoikis [45,46,47].